Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2008 1
2009 1
2010 3
2011 1
2012 6
2013 5
2014 8
2015 9
2016 9
2017 5
2018 14
2019 10
2020 16
2021 21
2022 27
2023 18
2024 19
2025 23
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

173 results

Results by year

Filters applied: . Clear all
Page 1
The effects of melissa officinalis on depression and anxiety in type 2 diabetes patients with depression: a randomized double-blinded placebo-controlled clinical trial.
Safari M, Asadi A, Aryaeian N, Huseini HF, Shidfar F, Jazayeri S, Malek M, Hosseini AF, Hamidi Z. Safari M, et al. BMC Complement Med Ther. 2023 May 2;23(1):140. doi: 10.1186/s12906-023-03978-x. BMC Complement Med Ther. 2023. PMID: 37131158 Free PMC article. Clinical Trial.
BACKGROUND: Depression is more common in diabetic patients, with a 1.5-fold increased risk of death.Melissa officinalis (M. officinalis) have anti-diabetic and anti-depression activities. The study aimed to determine the efficacy of M. officinalis extract on depress …
BACKGROUND: Depression is more common in diabetic patients, with a 1.5-fold increased risk of death.Melissa officinalis (M. officinal …
A multinational Delphi consensus to end the COVID-19 public health threat.
Lazarus JV, Romero D, Kopka CJ, Karim SA, Abu-Raddad LJ, Almeida G, Baptista-Leite R, Barocas JA, Barreto ML, Bar-Yam Y, Bassat Q, Batista C, Bazilian M, Chiou ST, Del Rio C, Dore GJ, Gao GF, Gostin LO, Hellard M, Jimenez JL, Kang G, Lee N, Matičič M, McKee M, Nsanzimana S, Oliu-Barton M, Pradelski B, Pyzik O, Rabin K, Raina S, Rashid SF, Rathe M, Saenz R, Singh S, Trock-Hempler M, Villapol S, Yap P, Binagwaho A, Kamarulzaman A, El-Mohandes A; COVID-19 Consensus Statement Panel. Lazarus JV, et al. Nature. 2022 Nov;611(7935):332-345. doi: 10.1038/s41586-022-05398-2. Epub 2022 Nov 3. Nature. 2022. PMID: 36329272 Free PMC article.
Research and product development for Crimean-Congo haemorrhagic fever: priorities for 2024-30.
Semper AE, Olver J, Warner J, Cehovin A, Fay PC, Hart PJ, Golding JP, Benassi V, Preziosi MP, Al-Asadi KHR, Blumberg LH, de la Fuente J, Elaldi N, Fletcher T, Formenty PBH, Gouya MM, Günther S, Hewson R, Jamil B, Kobinger G, Korukluoglu G, Lempereur L, Palacios G, Papa A, Pshenichnaya N, Schmaljohn C, Sow SO, Sprong H, Vatansever Z, Brooks TJG. Semper AE, et al. Lancet Infect Dis. 2025 Apr;25(4):e223-e234. doi: 10.1016/S1473-3099(24)00656-X. Epub 2024 Nov 7. Lancet Infect Dis. 2025. PMID: 39522529 Review.
Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV.
Taki E, Soleimani F, Asadi A, Ghahramanpour H, Namvar A, Heidary M. Taki E, et al. Expert Rev Anti Infect Ther. 2022 Aug;20(8):1135-1147. doi: 10.1080/14787210.2022.2081153. Epub 2022 Jun 13. Expert Rev Anti Infect Ther. 2022. PMID: 35596583 Review.
EXPERT OPINION: Based on the results of the ATLAS and FLAIR trials, Cabotegravir/Rilpivirine regimen once-monthly has shown equal effectivity to oral combination antiretroviral therapy (cART) in maintaining HIV-1 suppression in patients. Furthermore, ATLAS-2 M study reveal …
EXPERT OPINION: Based on the results of the ATLAS and FLAIR trials, Cabotegravir/Rilpivirine regimen once-monthly has shown equal effectivit …
Bacterial vaginosis toxins impair sperm capacitation and fertilization.
Bhagwat S, Asadi L, McCarthy R, Ferreira J, Li P, Li E, Spivak S, Gaydon A, Reddy V, Armstrong C, Morrill SR, Zhou H, Lewis AL, Lewis WG, Santi CM. Bhagwat S, et al. Hum Reprod. 2025 Sep 1;40(9):1720-1734. doi: 10.1093/humrep/deaf132. Hum Reprod. 2025. PMID: 40652342 Free PMC article.
STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Institutes of Health (grant number R01 HD069631 to C.M.S.). The authors declare that they have no conflict of interest....
STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Institutes of Health (grant number R01 HD069631 to C.M.S …
Clofazimine: A useful antibiotic for drug-resistant tuberculosis.
Mirnejad R, Asadi A, Khoshnood S, Mirzaei H, Heidary M, Fattorini L, Ghodousi A, Darban-Sarokhalil D. Mirnejad R, et al. Biomed Pharmacother. 2018 Sep;105:1353-1359. doi: 10.1016/j.biopha.2018.06.023. Epub 2018 Jun 29. Biomed Pharmacother. 2018. PMID: 30021373 Review.
Drug resistance is still the major threat to global tuberculosis (TB) control, and drug-resistant (DR) Mycobacterium tuberculosis (M. tuberculosis) strains have become the main challenge worldwide. Currently used antibiotics for treatment of DR-TB are often poorly tolerate …
Drug resistance is still the major threat to global tuberculosis (TB) control, and drug-resistant (DR) Mycobacterium tuberculosis (M. …
Influence of Maturation Stage on Agility Performance Gains After Plyometric Training: A Systematic Review and Meta-analysis.
Asadi A, Arazi H, Ramirez-Campillo R, Moran J, Izquierdo M. Asadi A, et al. J Strength Cond Res. 2017 Sep;31(9):2609-2617. doi: 10.1519/JSC.0000000000001994. J Strength Cond Res. 2017. PMID: 28557853
Asadi, A, Arazi, H, Ramirez-Campillo, R, Moran, J, and Izquierdo, M. Influence of maturation stage on agility performance gains after plyometric training: a systematic review and meta-analysis. ...
Asadi, A, Arazi, H, Ramirez-Campillo, R, Moran, J, and Izquierdo, M. Influence of maturation stage on agility performance gain …
Single-cell multi-ome and immune profiles of the Inspiration4 crew reveal conserved, cell-type, and sex-specific responses to spaceflight.
Kim J, Tierney BT, Overbey EG, Dantas E, Fuentealba M, Park J, Narayanan SA, Wu F, Najjar D, Chin CR, Meydan C, Loy C, Mathyk B, Klotz R, Ortiz V, Nguyen K, Ryon KA, Damle N, Houerbi N, Patras LI, Schanzer N, Hutchinson GA, Foox J, Bhattacharya C, Mackay M, Afshin EE, Hirschberg JW, Kleinman AS, Schmidt JC, Schmidt CM, Schmidt MA, Beheshti A, Matei I, Lyden D, Mullane S, Asadi A, Lenz JS, Mzava O, Yu M, Ganesan S, De Vlaminck I, Melnick AM, Barisic D, Winer DA, Zwart SR, Crucian BE, Smith SM, Mateus J, Furman D, Mason CE. Kim J, et al. Nat Commun. 2024 Jun 11;15(1):4954. doi: 10.1038/s41467-024-49211-2. Nat Commun. 2024. PMID: 38862516 Free PMC article.
173 results